,,iv #aag? ,,congress #a/ ,session ,h4 ,,res4 #djd ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,may #ag1 #bjba ,mrs4 ,d+ell 7= h]self1 ,mr4 ,joyce ( ,ohio1 ,mr4 ,butt]field1 ,mr4 ,cleav]1 ,ms4 ,spei]1 ,mr4 ,blum5au]1 ,mr4 ,coh51 ,ms4 ,williams ( ,georgia1 ,mr4 ,lev9 ( ,mi*igan1 ,ms4 ,dean1 ,mr4 ,deut*1 ,ms4 ,p+ree1 ,mr4 ,la,malfa1 ,ms4 ,salaz>1 ,mr4 ,connolly1 ,mr4 ,vela1 ,mr4 ,ru!r=d1 ,mrs4 ,walorski1 ,mr4 ,lamb1 ,mr4 ,ru%1 ,mr4 ,long1 & ,mr4 ,waltz7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = ! designation ( ! #ag? day 9 ,may z ,,dipg ,aw>5ess ,day to raise aw>5ess & enc\rage rese>* into cures = diffuse intr9sic pont9e glioma 7,,dipg7 & p$iatric canc]s 9 g5]al4 ,:]eas diffuse intr9sic pont9e glioma 7,,dipg7 affects #bjj to #djj *ildr5 9 ! ,unit$ ,/ates ea* ye> ) c]ta9 regul>ity2 ,:]eas bra9 tumors are ! lead+ cause ( canc]-relat$ dea? 9 *ildr52 ,:]eas ,,dipg is ! second mo/ common malignant bra9 tumor ( *ildhood2 ,:]eas ,,dipg is ! lead+ cause ( *ildhood dea? due to bra9 tumors2 ,:]eas ! m$ian survival "t is only #i mon?s po/diagnosis ) treatm5t2 ,:]eas #e-ye> survival is less ?an #a p]c5t2 ,:]eas1 giv5 ! age at diagnosis & ! av]age life expectancy1 ! numb] ( life ye>s lo/ annually because ( ,,dipg is approximately #bd1jjj ye>s ( p]son life lo/ 7calculat$ z ! numb] ( *ildr5 diagnos$ by av]age ( male & female life expectancy f t m$ian age1 #cjj #hj #bd1jjj ye>s ( p]son life lo/ annually72 ,:]eas prognosis has n improv$ = *ildr5 ) ,,dipg 9 ov] #dj ye>s2 & ,:]eas ,f$]al fund+ = rese>* = p$iatric canc] %\ld be increas$ to address ! level ( unmet m$ical ne$ = ?is vuln]able population3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 supports ! designation ( ,,dipg ,aw>5ess ,day2 7#b7 enc\rages all p ( ! ,unit$ ,/ates to become m in=m$ ab\t diffuse intr9sic pont9e glioma 7,,dipg7 p$iatric bra9 canc]1 & ! curr5t *all5ges to ! m$ical rese>* sy/em 9 designat+ suffici5t rese>* fund+ = p$iatric canc]s2 7#c7 supports exp&$ rese>* to bett] und]/& ,,dipg1 develop effective treatm5ts1 & provide compreh5sive c>e = *ildr5 ) ,,dipg & _! families2 & 7#d7 enc\rages public & private s\rces ( rese>* fund+ to elevate _! consid]ation ( ! mortality rate ( a type ( canc]1 z well z ! life-ye>s lo/1 z significant factors to be consid]$ dur+ ! grant application process4